Literature DB >> 17460387

Risk of developing low glomerular filtration rate or elevated serum creatinine in a screened cohort in Okinawa, Japan.

Kunitoshi Iseki1, Chiho Iseki, Yoshiharu Ikemiya, Kozen Kinjo, Shuichi Takishita.   

Abstract

There are no known predictors of renal dysfunction, particularly for a community-based screening. We evaluated the changes in serum creatinine (SCr) and glomerular filtration rate (GFR) among screenees who participated in the screening program of the Okinawa General Health Maintenance Association both in 1983 and 1993. A total of 4,662 screenees at least 30 years of age at the 1983 screening were analyzed to examine whether they developed high SCr (>or=1.4 mg/dl for men, >or=1.2 mg/dl for women) or low GFR (<60 ml/min/1.73 m2). Overall, mean GFR (mean+/-SD) decreased slightly from 72.7+/-11.7 ml/min/1.73 m2 to 70.8+/-15.0 ml/min/1.73 m2. In 1983, the prevalences of high SCr and low GFR were 3.6% and 13.2%, respectively, and in 1993, they were 8.1% and 24.2%, respectively. Among the variables studied, dipstick proteinuria was the strongest predictor: the adjusted odds ratio (95% CI) was 1.282 (1.076-1.527, p<0.01) for high SCr and 1.215 (1.116-1.322, p<0.01) for low GFR. Dipstick proteinuria was best for detecting subjects who might develop low GFR in a screening setting. In subjects without proteinuria, systolic blood pressure was a significant predictor for low GFR (the adjusted odds ratio [95% CI] was 1.015 [1.009-1.020, p<0.01]) and for high SCr (the adjusted odds ratio [95% CI] was 1.028 [1.016-1.040, p<0.01]). In conclusion, the present study suggests that a dipstick urine test for proteinuria and both systolic and diastolic blood pressure are useful to identify those who are at risk of developing high SCr and low GFR and consequently end-stage renal disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17460387     DOI: 10.1291/hypres.30.167

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  8 in total

1.  The state of U.S. living kidney donors.

Authors:  Connie L Davis; Mathew Cooper
Journal:  Clin J Am Soc Nephrol       Date:  2010-07-15       Impact factor: 8.237

2.  Proteinuria and decreased body mass index as a significant risk factor in developing end-stage renal disease.

Authors:  Kunitoshi Iseki; Kaori Tokashiki; Chiho Iseki; Kentaro Kohagura; Kozen Kinjo; Shuichi Takishita
Journal:  Clin Exp Nephrol       Date:  2008-06-27       Impact factor: 2.801

3.  Decreased body mass index as an independent risk factor for developing chronic kidney disease.

Authors:  Kaori Tokashiki; Masahiko Tozawa; Chiho Iseki; Kentaro Kohagura; Kozen Kinjo; Shuichi Takishita; Kunitoshi Iseki
Journal:  Clin Exp Nephrol       Date:  2008-10-07       Impact factor: 2.801

4.  Gender difference in relationship between body mass index and development of chronic kidney disease.

Authors:  Hiroshi Komura; Ikuo Nomura; Kazuo Kitamura; Kenji Kuwasako; Johji Kato
Journal:  BMC Res Notes       Date:  2013-11-13

5.  Chronic kidney disease and associated factors among adult population in Southwest Ethiopia.

Authors:  Kindie Mitiku Kebede; Dejene Derseh Abateneh; Melkamu Beyene Teferi; Abyot Asres
Journal:  PLoS One       Date:  2022-03-03       Impact factor: 3.240

6.  The prevalence of chronic kidney disease (CKD) and the associated factors to CKD in urban Korea: a population-based cross-sectional epidemiologic study.

Authors:  Suhnggwon Kim; Chun Soo Lim; Dong Cheol Han; Gyo Sun Kim; Ho Jun Chin; Seung-Jung Kim; Won Yong Cho; Yeong Hoon Kim; Yon-Su Kim
Journal:  J Korean Med Sci       Date:  2009-01-28       Impact factor: 2.153

7.  Prevalence of chronic kidney diseases and its determinants among perimenopausal women in a rural area of North India: A community-based study.

Authors:  H Salve; S Mahajan; P Misra
Journal:  Indian J Nephrol       Date:  2012-11

8.  Association between body mass index and chronic kidney disease: a population-based, cross-sectional study of a Japanese community.

Authors:  Ikuo Nomura; Johji Kato; Kazuo Kitamura
Journal:  Vasc Health Risk Manag       Date:  2009-04-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.